Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 3Completed 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Leukemia 37Lymphoma 12Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 4Leukemia, Biphenotypic, Acute 4Burkitt Lymphoma 4Neoplasm, Residual 3Myelodysplastic Syndromes 3Dendritic Cell Sarcoma, Interdigitating 3Anemia, Refractory, with Excess of Blasts 3Recurrence 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Extranodal NK-T-Cell 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Monocytic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Anemia, Refractory 2Thrombocytopenia 1Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neoplasms 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1

Interventions

fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 17Whole-Body Irradiation 15Mycophenolic Acid 14Cyclophosphamide 14Cyclosporine 12Busulfan 12Methotrexate 9Etoposide 9Tacrolimus 8Bortezomib 7Antilymphocyte Serum 7Everolimus 5Dexamethasone 5Vorinostat 4Rituximab 4Panobinostat 4Gemcitabine 4Flow Cytometry 4Carboplatin 4thymoglobulin 3Transplantation 3Therapeutics 3Radiotherapy 3Pharmacogenomic Testing 3Methylprednisolone 3Melphalan 3In Situ Hybridization, Fluorescence 3Gene Expression Profiling 3Early Intervention, Educational 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Lymphoma, Extranodal NK-T-Cell × Asparaginase × Clear all
NCT03079544 2021-09-14

Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Completed
665 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT00283985 2013-02-28

Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma

University Hospital, Limoges

Phase 2 Completed
40 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡